Table 3.
Phenotypes of T-cell-mediated experimental animal models in miR-155-deficient mice
| Model | Effector cells | Phenotype | Cytokines | References |
|---|---|---|---|---|
| CD4-dependent | ||||
| Tumour transplantation | Th1 | Enhanced tumour growth | IFN-γ↓ | 32 |
| Salmonella typhimurium | Th1 | Reduced optimal response | IFN-γ↓ | 11 |
| Delayed-type hypersensitivity | Th1, Th17 | Less severe | IL-17↓, IFN-γ↓, IL-6↓ | 26 |
| Helicobacter pyroli | Th1, Th17 | Bacteria not eliminated | IFN-γ↓, IL-17↓ | 27 |
| Asthma/HDM | Th2 | Less severe | IL-13↓ | 35 |
| Asthma/OVA | Th2 | Less severe | IL-4/5/13↓ | 33 |
| Heligmosomoides polygyrus | Th2 | Helminth not eliminated | IL-13↓ | 35 |
| Collagen-induced arthritis | Th17, Th1 | Less severe | IL-17↓, IFN-γ↓ | 12,13 |
| EAE | Th17, Th1 | Less severe | IL-17↓, IFN-γ↓ | 25,26 |
| Toxoplasma gondii | Th17, Th1 | Reduced optimal response | IL-17↓ | 36 |
| CD8-dependent | ||||
| Influenza | CD8 | Virus not eliminated | IFN-γ↓ | 46 |
| Listeria monocytogenes | CD8 | Reduced optimal response | IFN-γ↓ | 46,47 |
| Lymphocytic choriomeningitis | CD8 | Reduced optimal response | IFN-γ↓ | 47 |
| Murid herpesvirus 68 | CD8 | Virus not eliminated | IFN-γ↓ | 45 |
| Tumour transplantation | CD8 | Enhanced tumour growth | IFN-γ↓ | 32 |
EAE, experimental autoimmune encephalomyelitis; HDM, house dust mite; IFN-γ, interferon-γ; IL-6, interleukin-6; OVA, ovalbumin; Th, T helper.